Amrapali Industries Intrinsic Value
Amrapali Industries (AMRAPLIN) median intrinsic value is ₹8.28 from 7 valuation models (range ₹5–₹35), vs current price ₹17.56 — -52.8% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse AMRAPLIN balance sheet details for revenue, profit, balance sheet and cash flow data.
AMRAPLIN Valuation Methods Summary — DCF, Graham Number & P/E
Amrapali Industries intrinsic value across 7 models vs current price ₹17.56 — upside/downside and value range per method. Also explore AMRAPLIN share price data to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹5.27 | ₹4.22 - ₹6.32 | -70.0% | EPS: ₹0.24, Sector P/E: 12x |
| Book Value Method | asset | ₹12.69 | ₹11.42 - ₹13.96 | -27.7% | Book Value/Share: ₹12.69, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹35.12 | ₹31.61 - ₹38.63 | +100.0% | Revenue/Share: ₹16460.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹27.69 | ₹24.92 - ₹30.46 | +57.7% | EBITDA: ₹12.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹5.27 | ₹4.74 - ₹5.80 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹5.27 | ₹4.74 - ₹5.80 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹8.28 | ₹7.45 - ₹9.11 | -52.8% | EPS: ₹0.24, BVPS: ₹12.69 |
AMRAPLIN Intrinsic Value vs Market Price — All Valuation Models
Amrapali Industries fair value range ₹5–₹35 vs current market price ₹17.56 across 7 valuation models. For current market price and key ratios, visit Amrapali Industries screener.
AMRAPLIN Intrinsic Value Analysis — Undervalued or Overvalued?
Amrapali Industries median intrinsic value ₹8.28, current price ₹17.56 — Trading Above Calculated Value by 52.8%, margin of safety -100.0%.
What is the intrinsic value of AMRAPLIN?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Amrapali Industries (AMRAPLIN) is ₹8.28 (median value). With the current market price of ₹17.56, this represents a -52.8% variance from our estimated fair value.
The valuation range spans from ₹5.27 to ₹35.12, indicating ₹5.27 - ₹35.12.
Is AMRAPLIN undervalued or overvalued?
Based on our multi-method analysis, Amrapali Industries (AMRAPLIN) appears to be trading above calculated value by approximately 52.8%.
AMRAPLIN Financial Health — Key Ratios vs Industry Benchmarks
Amrapali Industries financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 31.67 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Asset Turnover Ratio | 356.63x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
AMRAPLIN Cash Flow Quality — Operating & Free Cash Flow
Amrapali Industries operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |